Merck & Co Inc <MRK.N>: Leerink Partners raises target price to $161 from $127
MRK•Related News
Kura Oncology launches Caspian Therapeutics, targets clinical proof-of-concept for diabetes drug KO-7246 after USD 50 million financing
KURA•
Chime shares jump 10% as Stride deal puts fintech on path to bank charter
CHYM•
Rezolute says FDA review continues for Phase 3 sunRIZE data on ersodetug in congenital hyperinsulinism
RZLT•
Centrus signs multi-year HALEU supply contract with Radiant for Kaleidos microreactors
LEU•
Oil tanker hit in Iraqi waters, as vessels get caught in US-Iran attacks
XLE•